The Australian wine giant is cutting production, idling vineyards and considering asset sales in America but a 40% surge in Penfolds’ China sales helped push underlying earnings above guidance.
On Aug. 10, TWE said it would restructure its U.S. operations by leaving some vineyards fallow, reducing inventory and writing down certain brand assets. The measures will result in an after-tax charge of A$558.4 million.
The restructuring follows a strategic review of TWE’s Americas business launched in June. Declining demand in the U.S. wine market has left the company with excess supply-chain capacity and elevated inventories.
As part of the overhaul, TWE will reduce production of North Coast vintage wine from 2026, including by leaving some vineyards fallow to lower its grape-purchasing requirements. The move will result in impairments against related assets across its U.S. operational network.
TWE will also write down inventory, principally bulk wine. The company expects to reduce those stocks through sales into the bulk-wine market and internal reclassification.
The brand impairment primarily involves American labels including DAOU, Frank Family Vineyards and Beaulieu Vineyard. TWE said the charges followed a review of asset carrying values as of June 30 and came on top of impairments already recognised in the first half of the 2026 financial year.
Asset Sales Remain Possible
Following the impairment announcement, TWE shares rose as much as 7.9% to A$5.86, their highest level since early December 2025. Investors appeared to welcome the company’s decision to tackle excess U.S. supply and inventory.
Marc Jocum, senior product and investment strategist at Global X ETFs, said investors appeared to appreciate TWE’s decisive action on a longstanding problem.
He added that the ongoing strategic review preserved flexibility for asset sales and a broader restructuring of the U.S. business, potentially supporting a longer-term revaluation of the company.
TWE’s own statement indicated that the U.S. overhaul is not yet complete.
“The operational and strategic review of the Americas remains ongoing, with Treasury Wine having appointed advisors to support the review of all available options across the Americas brand portfolio, operating model and asset base,” the company said.
The impairment may therefore be only one stage of TWE’s U.S. restructuring. Beyond reducing production and inventory, the company continues to consider other options, including potential asset disposals.
Penfolds Helps Lift EBITS Above Guidance
Despite the substantial impairment charge, TWE expects its results for the financial year ended June 30 to exceed its previous guidance.
The company said unaudited EBITS, earnings before interest, tax, SGARA and material items, is expected to reach A$492.3 million, above its earlier guidance range of A$480 million to A$490 million.
TWE also reaffirmed its expectation that EBITS in the 2027 financial year will be at least in line with the 2026 result.
Resilient sales from its key brands helped support the operating performance.
“The underlying momentum in our business remains positive, with our key brands delivering depletions growth ahead of their categories, led by Penfolds,” CEO Sam Fischer said.
China’s performance is drawing particular attention.
According to TWE’s results for the first half of the 2026 financial year, Penfolds generated A$354.7 million in sales across Asia, accounting for 70.76% of the brand’s total sales during the period.
TWE did not disclose sales for China separately. However, a quarterly trading update released in April showed that Penfolds sales through Chinese distributors jumped 40% year on year in the three months through February 2026, driven primarily by strong Lunar New Year demand for Bin 389 and Bin 407.
The result suggests that Penfolds has maintained comparatively strong momentum despite continued pressure across China’s broader wine market, including shrinking consumption occasions, channel inventories and price adjustments.
Wang Dehui, a Chinese wine branding and marketing specialist and general manager of Shenzhen Zhide Marketing Planning Co., said TWE’s performance could be viewed as “two sets of books”: impairments in the U.S. business on one side and continued healthy sales of Penfolds on the other.
“What TWE wants to tell investors is that because it has Penfolds – and particularly because of the recovery in China – it has a backstop,” Wang said. “That gives it confidence that the business will not collapse and allows it to cut through the problems decisively and give shareholders an explanation.”
Is TWE Prioritising Sustainable Growth in China?
Penfolds’ momentum in China is not without pressure.
Although Bin 389 and Bin 407 remain among the country’s best-known imported wines, demand no longer resembles the period before 2020, when the labels frequently sold out during peak seasons.
As Vino Joy News previously reported, TWE suspended new orders of Bin 407 from Chinese distributors in July for an expected period of one quarter. Industry observers widely interpreted the move as an attempt to give distributors time to reduce inventories.
Wang said the supply restriction did not mean the Chinese market had fully recovered.
Supply controls are common in the baijiu industry and essentially sacrifice short-term shipments to improve channel inventory and restore pricing discipline. Viewed in that context, TWE’s restrictions on Bin 407 also indicate that it is prioritising the long-term health of its China business.
The scale of TWE’s impairment highlights how deeply the imbalance between supply and demand in the U.S. wine market is affecting major global wine groups. Penfolds’ relative resilience in China, meanwhile, has become an important support for the company’s earnings outlook.
Vino Joy News will continue to monitor TWE’s full-year results and the outcome of its strategic review of the Americas.
Discover more from Vino Joy News
Subscribe to get the latest posts sent to your email.
